Literature DB >> 33485447

Neuropathology associated with SARS-CoV-2 infection - Authors' reply.

Claus Hann von Weyhern1, Ines Kaufmann2, Frauke Neff1, Marcus Kremer3.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33485447      PMCID: PMC7825920          DOI: 10.1016/S0140-6736(21)00097-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
We welcome the opportunity to respond to the comments about our Correspondence. To increase the availability of data, we reported our findings, which were produced by a team that included an experienced neuropathologist and was subjected to the The Lancet's peer-review process. The three responses are similar as they all challenge our interpretation of the findings presented. Striking is the fact that the three responses disagree among themselves, with each offering yet another interpretation. To analyse our findings, we consulted a standard neuropathology textbook, coauthored by one of our critics. In the textbook, one reads that glial cells indeed can be differentiated from non-glial cells, and that hypoxic neurons can be distinguished from dark neurons based on classical haematoxylin and eosin staining. In the absence of specific morphological alterations, shrinking is often the only indication of necrosis or apoptosis. Aware of the hypoxic origin of similar morphological alterations, we used the general level of hypoxic injury to vulnerable CA1 areas of the hippocampus and Purkinje cells in the cerebellum as a baseline. Because we did not observe hypoxic injury in these areas, we do not attribute the observed morphological alterations to hypoxia.We concede that the term pan-encephalitis was poorly chosen. In the neuropathological literature, pan-encephalitis refers to a fulminant necrotic disease, which we clearly did not observe. However, both MacLean Nasrallah and colleagues and a more recent report point out that patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit signs of the observed disseminated encephalitis as well as aseptic meningitis. Whether this observation is a general feature of SARS-CoV-2 infection should be established through extensive studies of a larger set of patients. It is suggested that we over-interpreted petechial haemorrhage. We agree that petechial haemorrhages are a common finding in autopsies of terminally ill patients, although they are most often localised in the occipital lobe and basal ganglia. In our group of patients, petechial haemorrhaging was located in the frontal and high parietal area and pronounced in the white matter (purpura cerebri-like). Beside the fact that reports of petechial bleeding in the brains of SARS-Cov-2 fatalities are mounting, a fact also alluded to by Nasrallah and colleagues, the massive haemorrhaging observed in our group of patients is certainly not an over-interpretation.3, 4, 5, 6, 7 Considering the ongoing global pandemic, we are happy that our Correspondence has generated a lively discussion and can only hope that the various hypotheses discussed in this exchange will be subjected to systematic rigorous analysis in a larger sample.
  6 in total

1.  Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology.

Authors:  R Ross Reichard; Kianoush B Kashani; Nicholas A Boire; Eleni Constantopoulos; Yong Guo; Claudia F Lucchinetti
Journal:  Acta Neuropathol       Date:  2020-05-24       Impact factor: 17.088

2.  Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.

Authors:  Claus Hann von Weyhern; Ines Kaufmann; Frauke Neff; Marcus Kremer
Journal:  Lancet       Date:  2020-06-04       Impact factor: 79.321

3.  Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.

Authors:  Zane Jaunmuktane; Ula Mahadeva; Anna Green; Vivek Sekhawat; Nicholas A Barrett; Lucy Childs; Manu Shankar-Hari; Maria Thom; Hans Rolf Jäger; Sebastian Brandner
Journal:  Acta Neuropathol       Date:  2020-07-08       Impact factor: 17.088

Review 4.  Lifting the mask on neurological manifestations of COVID-19.

Authors:  Alessandro Pezzini; Alessandro Padovani
Journal:  Nat Rev Neurol       Date:  2020-08-24       Impact factor: 42.937

Review 5.  COVID-19: A Global Threat to the Nervous System.

Authors:  Igor J Koralnik; Kenneth L Tyler
Journal:  Ann Neurol       Date:  2020-07       Impact factor: 11.274

6.  Non-aneurysmal subarachnoid haemorrhage in COVID-19.

Authors:  Suzanne Harrogate; Alex Mortimer; Lorna Burrows; Barnaby Fiddes; Ian Thomas; Claire M Rice
Journal:  Neuroradiology       Date:  2020-08-28       Impact factor: 2.804

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.